• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

DarioHealth inks deal to use blood glucose tech in pharma company’s clinical trial

February 9, 2018 By Sarah Faulkner

DarioHealthDarioHealth (NSDQ:DRIO) said today that it inked a deal with an unnamed pharmaceutical company to combine its blood glucose monitoring tech into the company’s clinical trial.

The Israel-based device-maker reported that this pharmaceutical company is conducting a trial of its diabetes drug that will eventually be included in a regulatory package for FDA approval.

DarioHealth has been tasked with tracking the blood glucose levels of the trial’s participants.

“We are thrilled to have been chosen for this important clinical study. Our Dario all-in-one platform was selected because of its ability to help patients in all aspects of managing diabetes with stronger user engagement, and real-time access to results. This move into clinical studies and clinician practices shows the adoption of our products and solutions going beyond the scope of just the consumer,” chairman & CEO Erez Raphael said in prepared remarks.

“We believe that this initial adoption of DarioHealth’s BGM platform by the clinical side of the industry will broaden our revenue stream beyond the device and strip business. By doing so, we will be able to make key learnings as we continue to develop new products and services to improve the greater healthcare ecosystem. Our vision for the future includes more solutions that pick up where the Dario blood glucose monitoring system ends and I believe this all begins today, as we assist a pharmaceutical company in their clinical study,” he added.

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Clinical Trials, Diabetes, Featured, Patient Monitoring, Pharmaceuticals, Wall Street Beat Tagged With: dariohealth

IN CASE YOU MISSED IT

  • Elixir Medical reports sustained durability with bioadaptor compared to Medtronic stent
  • Senseonics closes public offering, private placement with Abbott
  • Embecta eyes shift from insulin delivery to broader medical supplies focus
  • Medtronic earns expanded CE mark for Prevail paclitaxel-coated balloon
  • Sequel Med Tech to pair automated insulin delivery system with Abbott’s future dual glucose-ketone sensor

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS